July 10, 2001--MOGUL ENTERPRISES, Inc. Receives FDA Clearance to Market Its 6-French, 20-Electrode Electrophysiology Diagnostic Catheter

SAN JOSE, CA.---July 10, 2001–MOGUL ENTERPRISES, Inc. (A privately held corporation) today announced that it received US Food and Drug Administration clearance of its 6-French, 20-Electrode Electrophysiology Diagnostic Catheter. The clearance includes steerable and fixed curve distal shaft versions of the catheter design.

Jamil Mogul, CEO/Chairperson of MOGUL ENTERPRISES, stated, "During electrophysiology study, our 6-French, 20-electrode catheter will help physicians overcome difficult challenges in performing global mapping and/or activation assessment in the right atrium, specifically, in cases of electrogram recording of the tricuspid valve annulus, evaluation of right free wall accessory pathways, and characterization of anteroseptal and right posteroseptal accessory pathways and Mahaim fibers. This catheter has the following main features:

  • The catheter shaft size is 6 French (.080 inch nominal)
  • The distal shaft contains up to twenty recording electrodes to encompass wider intracardiac region
  • The steerable distal shaft has two versions: unidirectional and bi-directional to access and diagnose different intracardiac regions in the chamber
  • The fixed curve of the distal shaft can be formed in accordance with the requirements of a physician
  • The distal shaft can have various lengths for various size heart chambers
  • The recording electrodes can have various lengths and inter-electrode spacing
  • Both the distal and proximal shafts can be soft or stiff
  • The proximal shaft is wire-braided for better torque transmissibility"

MOGUL ENTERPRISES, Inc. is a startup medical company that is dedicated to developing innovative and inexpensive medical devices/instrumentation related to cardiovascular Rx/Dx and minimally invasive/general surgery for filling the needs of budget-constrained and cost-conscious hospitals in the USA, Europe, Japan and emerging-market countries.

Jamil Mogul stated, "We believe that affordability of this device and the other medical devices and instrumentation that are under development at MOGUL ENTERPRISES will help provide an access of modern diagnostic, therapeutic/surgical procedures to millions of patients in small cities/towns in the USA, Canada, Europe, Asia, Africa, Latin (North & South) America, Australia and New Zealand"

He also indicated, "Our 6-French, 20-Electrode electrophysiology diagnostic catheter will be cost competitive enough to be affordable to the budget-constrained hospitals that have a great need of an electrophysiology catheter of this size in their cardiac catheter laboratories. It will generally be priced 30% below the competition while offering more features and better performance than the competitive catheters in this French size."

MOGUL ENTERPRISES, Inc. needs to expand its manufacturing facility to produce this catheter in a higher volume for commercialization. Therefore, it is searching for investment partners to join the company and receive founders’ stock in exchange for their financial investment.. Simultaneously, it intends to offer an exclusive license on a territory basis to manufacture and/or distribute the product.

Contact: Jamil Mogul at 1-408-629-3340 (office) or 1-408-489-2083 (mobile) or e-mail: TheMOGULS@aol.com